⚠ GRFS is no longer actively traded.
Data shown reflects verified historical relationships.
0Suppliers
0Customers
1Debt Items
20Related Chains
Grifols, S.A. Suppliers
No suppliers on recordGrifols, S.A. has not yet been matched to upstream suppliers in our database, or is still being processed.
Grifols, S.A. Customers
No clients on recordNo downstream customers found in our database for Grifols, S.A..
Grifols, S.A. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| GRFS-DEBT |
Debt stack $11.2B |
90%
|
Market cache reports total debt of $11.2B. |
Grifols, S.A. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Grifols, S.A..
Grifols, S.A. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| GRFS-OWNER-BRANDES-INVESTMENT-PARTNERS-LP |
BRANDES INVESTMENT PARTNERS, LP |
90%
|
13F overlay lists BRANDES INVESTMENT PARTNERS, LP as top holder; 185 tracked holders. |
Grifols, S.A. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| DBVTF |
DBV TECHNOLOGIES |
100.00 |
2 |
|
| ALXO |
ALX Oncology Holdings Inc. |
100.00 |
2 |
|
| AZN |
AstraZeneca PLC |
100.00 |
2 |
|
| BLRX |
BioLineRx Ltd. |
100.00 |
2 |
|
| CTMX |
CytomX Therapeutics, Inc. |
100.00 |
2 |
|
| ANL |
Adlai Nortye Ltd. |
100.00 |
2 |
|
| PSNL |
Personalis, Inc. |
100.00 |
2 |
|
| AORT |
Artivion, Inc. |
100.00 |
2 |
|
| GRAL |
GRAIL, Inc. |
100.00 |
2 |
|
| CYTOF |
Altamira Therapeutics Ltd. |
100.00 |
2 |
|
| BIOA |
BioAge Labs, Inc. |
100.00 |
2 |
|
| CYTK |
Cytokinetics, Incorporated |
100.00 |
2 |
|
| BEAM |
Beam Therapeutics Inc. |
100.00 |
2 |
|
| CBIO |
Crescent Biopharma, Inc. |
100.00 |
2 |
|
| ANRO |
Alto Neuroscience, Inc. |
100.00 |
2 |
|
| WHWK |
Whitehawk Therapeutics, Inc. |
100.00 |
2 |
|
| ALVO |
Alvotech |
100.00 |
2 |
|
| CCEP |
Coca-Cola Europacific Partners PLC |
100.00 |
2 |
|
| DSGN |
Design Therapeutics, Inc. |
100.00 |
2 |
|
| EDIT |
Editas Medicine, Inc. |
100.00 |
2 |
|
